Literature DB >> 16340955

Bone morphogenetic protein signalling and vertebrate nervous system development.

Aimin Liu1, Lee A Niswander.   

Abstract

Transforming growth factor-beta (TGFbeta) signalling, particularly signalling from the bone morphogenetic protein (BMP) members of this protein family, is crucial for the development of both the central and peripheral nervous systems in vertebrates. Experimental embryology and genetics performed in a range of organisms are providing insights into how BMPs establish the neural tissue and control the types and numbers of neurons formed. These studies also highlight the interactions between different developmental signals that are necessary to form a functional nervous system. The challenges ahead will be to uncover functions of TGFbeta signalling in later stages of CNS development, as well as to determine possible associations with neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16340955     DOI: 10.1038/nrn1805

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  129 in total

1.  Canonical BMP7 activity is required for the generation of discrete neuronal populations in the dorsal spinal cord.

Authors:  Gwenvael Le Dréau; Lidia Garcia-Campmany; M Angeles Rabadán; Tiago Ferronha; Samuel Tozer; James Briscoe; Elisa Martí
Journal:  Development       Date:  2011-12-07       Impact factor: 6.868

2.  ZFP423 coordinates Notch and bone morphogenetic protein signaling, selectively up-regulating Hes5 gene expression.

Authors:  Giacomo Masserdotti; Aurora Badaloni; Yangsook Song Green; Laura Croci; Valeria Barili; Giorgio Bergamini; Monica L Vetter; G Giacomo Consalez
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

3.  Homeodomain interacting protein kinase 2 regulates postnatal development of enteric dopaminergic neurons and glia via BMP signaling.

Authors:  Alcmène Chalazonitis; Amy A Tang; Yulei Shang; Tuan D Pham; Ivy Hsieh; Wanda Setlik; Michael D Gershon; Eric J Huang
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

4.  Modeling of human neurulation using bioengineered pluripotent stem cell culture.

Authors:  Xufeng Xue; Ryan P Wang; Jianping Fu
Journal:  Curr Opin Biomed Eng       Date:  2020-02-17

Review 5.  Genetic networks controlling the development of midbrain dopaminergic neurons.

Authors:  Nilima Prakash; Wolfgang Wurst
Journal:  J Physiol       Date:  2006-07-06       Impact factor: 5.182

6.  SMAD7 directly converts human embryonic stem cells to telencephalic fate by a default mechanism.

Authors:  Mohammad Zeeshan Ozair; Scott Noggle; Aryeh Warmflash; Joanna Ela Krzyspiak; Ali H Brivanlou
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

7.  Potential frameworks to support evaluation of mechanistic data for developmental neurotoxicity outcomes: A symposium report.

Authors:  Laura M Carlson; Frances A Champagne; Deborah A Cory-Slechta; Laura Dishaw; Elaine Faustman; William Mundy; Deborah Segal; Christina Sobin; Carol Starkey; Michele Taylor; Susan L Makris; Andrew Kraft
Journal:  Neurotoxicol Teratol       Date:  2020-02-14       Impact factor: 3.763

8.  Differential modulation of nerve growth factor receptor (p75) and cholinergic gene expression in purified p75-expressing and non-expressing basal forebrain neurons by BMP9.

Authors:  Aletta C Schnitzler; Ignacio Lopez-Coviella; Jan Krzysztof Blusztajn
Journal:  Brain Res       Date:  2008-10-14       Impact factor: 3.252

9.  SoxB1-driven transcriptional network underlies neural-specific interpretation of morphogen signals.

Authors:  Tony Oosterveen; Sanja Kurdija; Mats Ensterö; Christopher W Uhde; Maria Bergsland; Magnus Sandberg; Rickard Sandberg; Jonas Muhr; Johan Ericson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

Review 10.  Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience.

Authors:  Jerome Mertens; Maria C Marchetto; Cedric Bardy; Fred H Gage
Journal:  Nat Rev Neurosci       Date:  2016-05-19       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.